Aaron Goodman: Our new prospective study in smoldering myeloma
Aaron Goodman shared a post by Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, on X/Twitter:
“Pleased to announce our new prospective study in smoldering myeloma. Pharma won’t fund such a study unless we give lots of drugs forever to healthy patients so we paid for it. Manni Mohyuddin and Raj Chakraborty the brains behind it.”
Quoting Manni Mohyuddin’s post:
“I am so thankful to everyone that made this happen, including the voices of patient advocates. I am also very thankful to Aaron Goodman whose funding from philanthropy helped make this study a reality. Thank you for reading!”
Source: Aaron Goodman/X and Manni Mohyuddin/X
Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023